BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11100730)

  • 1. Binding of disease-associated prion protein to plasminogen.
    Fischer MB; Roeckl C; Parizek P; Schwarz HP; Aguzzi A
    Nature; 2000 Nov; 408(6811):479-83. PubMed ID: 11100730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of recombinant PrPc to human plasminogen: kinetic and thermodynamic study using a resonant mirror biosensor.
    Cuccioloni M; Amici M; Eleuteri AM; Biagetti M; Barocci S; Angeletti M
    Proteins; 2005 Feb; 58(3):728-34. PubMed ID: 15609351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
    Xanthopoulos K; Paspaltsis I; Apostolidou V; Petrakis S; Siao CJ; Kalpatsanidis A; Grigoriadis N; Tsaftaris A; Tsirka SE; Sklaviadis T
    Neurobiol Dis; 2005 Nov; 20(2):519-27. PubMed ID: 15922607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen stimulates propagation of protease-resistant prion protein in vitro.
    Mays CE; Ryou C
    FASEB J; 2010 Dec; 24(12):5102-12. PubMed ID: 20732953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
    Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
    EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
    Touil F; Pratt S; Mutter R; Chen B
    J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
    Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
    J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
    Saborio GP; Permanne B; Soto C
    Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
    Jeffrey M; McGovern G; Sisó S; González L
    Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
    White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
    Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro self-propagation of recombinant PrPSc-like conformation generated in the yeast cytoplasm.
    Yang W; Yang H; Tien P
    FEBS Lett; 2006 Jul; 580(17):4231-5. PubMed ID: 16831424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
    Lucassen R; Nishina K; Supattapone S
    Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody.
    Moroncini G; Mangieri M; Morbin M; Mazzoleni G; Ghetti B; Gabrielli A; Williamson RA; Giaccone G; Tagliavini F
    Neurobiol Dis; 2006 Sep; 23(3):717-24. PubMed ID: 16876426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
    Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
    Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight prion strains have PrP(Sc) molecules with different conformations.
    Safar J; Wille H; Itri V; Groth D; Serban H; Torchia M; Cohen FE; Prusiner SB
    Nat Med; 1998 Oct; 4(10):1157-65. PubMed ID: 9771749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.